Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China

Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China

Abstract Background Prostaglandin analogs (PGAs) are the first-line treatment for primary open-angle glaucoma (POAG) and ocular hypertension (OH). This study aimed to confirm the effectiveness and safety of Tapros® (0.0015% tafluprost eye drops) in Chinese patients with POAG and OH. Methods This pha...

Full description

Bibliographic Details
Main Authors: Xinghuai Sun, Qinghuai Liu, Xin Tang, Ke Yao, Yan Li, Jin Yang, Mingchang Zhang, Huiping Yuan, Yan Zheng, Weining Li, Huacong Peng
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Ophthalmology
Subjects:
Tafluprost
Primary open-angle glaucoma
Ocular hypertension
Clinical trial
Phase IV
China
Online Access:https://doi.org/10.1186/s12886-022-02553-1

Internet

https://doi.org/10.1186/s12886-022-02553-1

Similar Items